Key result
ISGylation of the Hepatitis C virus NS5A protein at specific lysine residues, particularly K308, promotes viral RNA replication by enhancing the recruitment of cyclophilin A.
HCV hijacks intracellular ISG15 function via HERC5 E3 ligase to promote viral replication, identifying HERC5 as a potential therapeutic target.
NS5A may enable HCV immune escape; leaves open whether ISG15 pathway targeting advances antivirals.
Host cells have evolved host defense machinery (such as innate immunity) to eliminate viral infections. Viruses have evolved several counteracting strategies for achieving an immune escape from host defense machinery, including type I interferons (IFNs) and inflammatory cytokines. ISG15 is an IFN-inducible ubiquitin-like protein that is covalently conjugated to the viral protein via specific Lys residues and suppresses viral functions and viral propagation. Here, we demonstrate that HCV NS5A protein accepts ISG15 conjugation at specific Lys residues and that the HERC5 E3 ligase specifically promotes NS5A ISGylation. We obtained evidence suggesting that NS5A ISGylation facilitates the recruitment of CypA, which is the critical host factor for HCV replication, thereby promoting HCV replication. These findings indicate that E3 ligase HERC5 is a potential therapeutic target for HCV infection. We propose that HCV hijacks an intracellular ISG15 function to escape the host defense machinery in order to establish a persistent infection.
No takes yet. Share an insight, caveat, or question.
Abe et al. (2020) studied Hepatitis C Virus (HCV) infection. NS5A ISGylation vs. Mutant NS5A lacking ISGylation sites (e.g., K308R) was evaluated on HCV RNA replication and NS5A-CypA interaction. ISGylation of the Hepatitis C virus NS5A protein at specific lysine residues, particularly K308, promotes viral RNA replication by enhancing the recruitment of cyclophilin A.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: